YEH1 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Context of YEH1

YEH1 (Systematic name: YLL012) encodes a steryl ester hydrolase involved in lipid particle homeostasis. Key features include:

  • Function: Catalyzes the hydrolysis of steryl esters to free sterols and fatty acids, critical for membrane remodeling under stress conditions .

  • Localization: Found in intracellular lipid particles, with both N- and C-termini exposed to the cytoplasm .

  • Regulation: Expression is upregulated under heme-deficient conditions, enabling sterol storage mobilization .

Development and Validation of YEH1 Antibody

YEH1 antibodies are typically monoclonal or polyclonal reagents developed using recombinant YEH1 protein or peptide epitopes. Validation strategies include:

Validation MethodApplicationKey Findings
Western BlotSpecificity confirmationDetects a single band at ~75 kDa (predicted molecular weight of YEH1) .
ImmunofluorescenceSubcellular localizationColocalizes with lipid droplets in yeast cells .
Genetic Knockout (KO)Functional specificityLoss of signal in yeh1Δ strains confirms antibody specificity .

These methods align with best practices for antibody validation, as emphasized in large-scale studies .

Research Applications

YEH1 antibodies have been pivotal in elucidating:

  • Lipid Storage Dynamics: Yeh1 hydrolyzes steryl esters during heme deficiency, enabling sterol redistribution for membrane integrity .

  • Interactions with Lipid Droplets: GFP-tagged YEH1 localizes to lipid particles, confirmed via fluorescence microscopy .

  • Genetic Pathways: Collaborative roles with paralogs YEH2 and TGL1 in lipid homeostasis .

Key Yeast Strains in YEH1 Studies

The following strains are critical for functional analyses (adapted from ):

StrainGenotypeApplication
YRS2090MATα yeh1::HIS3MX6 tgl1::kanMX4 YEH1-GFP-TRP1Localization studies
YRS2184MATa GAL1-GFP-YEH1 hem1::LEU2Heme-deficient regulation assays
YRS2740MATa rox3::kanMX4 YEH1-GFP-HIS3MX6 hem1::LEU2Transcriptional regulation analysis

Challenges and Considerations

  • Cross-Reactivity: Potential overlap with homologous proteins (e.g., YEH2) necessitates rigorous validation using KO controls .

  • Epitope Accessibility: Membrane-associated localization of Yeh1 requires permeabilization for antibody binding in fixed cells .

Future Directions

Advances in recombinant antibody engineering (e.g., Fc silencing, half-life extension) could enhance YEH1 antibody utility for in vivo tracking. Additionally, CRISPR-based tagging and mass spectrometry may refine spatial-temporal resolution of Yeh1 activity.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YEH1 antibody; YLL012W antibody; L1329 antibody; Sterol esterase 1 antibody; EC 3.1.1.13 antibody; Steryl ester hydrolase 1 antibody
Target Names
YEH1
Uniprot No.

Target Background

Function
YEH1 Antibody is a key enzyme in lipid metabolism, mediating the hydrolysis of steryl esters. Under conditions where heme is deficient, YEH1 becomes the primary steryl ester hydrolase, highlighting its critical role in mobilizing steryl esters during anaerobic conditions.
Gene References Into Functions
  1. This research demonstrates a strong regulatory mechanism for the two lipid droplet-associated steryl ester hydrolases, Tgl1p and Yeh1p, influenced by the presence or absence of their host organelle. PMID: 28866104
  2. Yeh1 is the sole active steryl ester hydrolase when heme is deficient, indicating that Yeh1 is activated while Yeh2 and Tgl1 are inactivated by the lack of heme. PMID: 16835446
Database Links

KEGG: sce:YLL012W

STRING: 4932.YLL012W

Protein Families
AB hydrolase superfamily
Subcellular Location
Lipid droplet. Membrane; Peripheral membrane protein.

Q&A

What is YEH1 and why is it important in research contexts?

YEH1 (encoded by the YEH1 gene) is a steryl ester hydrolase primarily found in Saccharomyces cerevisiae (Baker's yeast). This protein is significant in research because it plays a role in lipid metabolism pathways, particularly in the hydrolysis of steryl esters. The study of YEH1 and its antibodies contributes to our understanding of fundamental cellular processes in eukaryotic organisms. When conducting research with YEH1 antibodies, it's important to note that these reagents are typically used to detect and quantify the YEH1 protein in yeast samples, with applications in western blotting, immunoprecipitation, and immunohistochemistry protocols. Researchers often use YEH1 antibodies to investigate lipid homeostasis mechanisms in yeast as a model organism .

What are the optimal storage conditions for YEH1 antibodies to maintain reactivity?

YEH1 antibodies, like most research-grade antibodies, require specific storage conditions to maintain their reactivity and specificity. The optimal storage conditions typically include maintaining the antibody at -20°C for long-term storage, with aliquoting recommended to avoid repeated freeze-thaw cycles that can degrade antibody performance. For working solutions, storage at 4°C for up to one month is generally acceptable.

To preserve antibody function:

  • Aliquot upon receipt to minimize freeze-thaw cycles

  • Store concentrated stock solutions at -20°C

  • Add carriers like BSA (0.1-1%) to dilute solutions to prevent adsorption to storage tubes

  • Avoid exposure to light for fluorophore-conjugated antibodies

  • Document the freeze-thaw history of each aliquot

Researchers should validate the activity of stored antibodies periodically, especially when using them for quantitative applications in YEH1 protein research .

What controls should be included when using YEH1 antibodies in western blot applications?

When conducting western blot experiments with YEH1 antibodies, proper controls are essential for reliable and interpretable results. The following controls should be incorporated:

Control TypePurposeImplementation
Positive ControlConfirms antibody reactivityLysate from wild-type S. cerevisiae expressing YEH1
Negative ControlEstablishes specificityLysate from YEH1 knockout yeast strain
Loading ControlNormalizes protein quantitiesAntibody against housekeeping protein (e.g., Act1)
Secondary Antibody ControlDetects non-specific bindingPrimary antibody omitted, secondary antibody only
Blocking Peptide ControlConfirms epitope specificityPre-incubation of antibody with YEH1 peptide

The inclusion of these controls helps distinguish true signals from artifacts and enables accurate quantification of YEH1 protein levels. When interpreting results, researchers should look for a single band at the expected molecular weight of YEH1 (~66 kDa) in positive controls, with absence of this band in negative controls .

How can researchers optimize immunoprecipitation protocols for YEH1 detection in different yeast growth conditions?

Optimizing immunoprecipitation (IP) protocols for YEH1 detection requires careful consideration of yeast growth conditions, as YEH1 expression and post-translational modifications may vary significantly depending on cellular metabolic states. To achieve robust and reproducible results:

  • Growth condition optimization:

    • Compare YEH1 expression in fermentative vs. respiratory growth

    • Monitor expression changes during different growth phases

    • Assess the impact of carbon source variation on YEH1 levels

  • Lysis buffer considerations:

    • Use buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40

    • Include protease inhibitors to prevent degradation

    • Add phosphatase inhibitors if studying YEH1 phosphorylation states

    • Consider detergent selection based on YEH1's membrane association

  • IP protocol refinements:

    • Pre-clear lysates to reduce non-specific binding

    • Optimize antibody-to-lysate ratios (typically 2-5 μg antibody per 500 μg protein)

    • Extend incubation times (4-16 hours at 4°C) for low-abundance conditions

    • Use gentle washing conditions to preserve weak interactions

  • Validation steps:

    • Confirm specificity using YEH1 knockout strains

    • Perform reciprocal IPs with known interaction partners

    • Compare results across different antibody clones if available

For quantitative comparisons between conditions, researchers should normalize IP efficiency using spike-in controls and carefully document all procedural variables .

What are the most effective epitope tagging strategies for studying YEH1 when antibody detection is challenging?

When direct detection of native YEH1 proves challenging due to antibody limitations, epitope tagging provides a valuable alternative approach. The effectiveness of different tagging strategies depends on several factors:

  • Tag selection considerations:

    • Small tags (HA, FLAG, Myc) minimize functional interference

    • GFP/fluorescent protein tags enable live-cell imaging but may affect function

    • Tandem tags (3xFLAG, 6xHis) enhance detection sensitivity

    • Split tags can help assess protein topology

  • Tag placement optimization:

    • C-terminal tagging is generally less disruptive for YEH1

    • Avoid disrupting known functional domains

    • Consider creating multiple constructs with different tag positions

    • Validate that tagged versions maintain wild-type localization patterns

  • Expression system selection:

    • Genomic integration under native promoter preserves physiological expression

    • Plasmid-based expression offers flexibility but may cause overexpression artifacts

    • Inducible promoters allow temporal control of expression

  • Functional validation requirements:

    • Complementation assays in YEH1 deletion strains

    • Growth phenotype analysis under lipid metabolism challenge conditions

    • Enzymatic activity assays to confirm hydrolase function

How can researchers differentiate between YEH1 and YEH2 in experimental systems using antibody-based detection methods?

Differentiating between the closely related steryl ester hydrolases YEH1 and YEH2 in yeast can be challenging due to their structural and functional similarities. To achieve specific detection:

  • Antibody selection strategies:

    • Use antibodies raised against unique epitopes not conserved between YEH1 and YEH2

    • Perform extensive cross-reactivity testing against purified proteins

    • Consider using monoclonal antibodies targeted to divergent regions

  • Experimental verification approaches:

    • Include both YEH1 and YEH2 knockout controls

    • Perform parallel immunoblotting with both antibodies

    • Use differential molecular weight migration patterns (YEH1: ~66 kDa, YEH2: ~62 kDa)

  • Enhanced specificity techniques:

    • Employ epitope competition assays with specific peptides

    • Utilize immunodepletion to remove cross-reactive antibodies

    • Consider two-color Western blotting for simultaneous detection

  • Alternative strategies when antibody specificity is insufficient:

    • Implement isoform-specific epitope tagging

    • Utilize mass spectrometry for definitive identification

    • Consider CRISPR-based endogenous tagging to maintain native expression levels

When interpreting results, researchers should account for potential functional redundancy and compensatory regulation between YEH1 and YEH2, which may complicate phenotypic analyses in single knockout systems .

How can YEH1 antibodies be utilized in high-throughput screening approaches to identify lipid metabolism modifiers?

YEH1 antibodies can serve as powerful tools in high-throughput screening (HTS) platforms designed to identify compounds or genetic factors that modulate lipid metabolism pathways. Effective implementation requires:

  • Assay development considerations:

    • Adapt YEH1 antibody detection to microplate formats

    • Optimize signal-to-noise ratio for automated detection systems

    • Develop quantitative readouts (e.g., fluorescence intensity, FRET-based systems)

    • Implement parallel viability assays to exclude cytotoxic effects

  • Screening platform design:

    • Primary screen: Monitor changes in YEH1 protein levels or post-translational modifications

    • Secondary screen: Assess effects on steryl ester hydrolase activity

    • Tertiary screen: Evaluate cellular lipid composition changes

  • Technical adaptations for HTS compatibility:

    • Develop homogeneous assay formats to minimize washing steps

    • Implement automated image analysis for high-content screens

    • Optimize reagent concentrations for miniaturized reaction volumes

    • Establish robust statistical parameters for hit identification

  • Validation strategies for identified modulators:

    • Dose-response relationships in secondary assays

    • Orthogonal methods to confirm specificity for YEH1-dependent pathways

    • Structure-activity relationship analysis for chemical modulators

    • Genetic interaction studies for gene modifiers

For maximum relevance, researchers can extend findings from yeast-based screens to mammalian systems, exploring whether identified modulators affect related mammalian lipid metabolism pathways. This translation requires careful consideration of evolutionary conservation and metabolic pathway differences .

What are the most sensitive techniques for detecting post-translational modifications of YEH1 using modification-specific antibodies?

Detecting post-translational modifications (PTMs) of YEH1 requires highly sensitive and specific techniques, particularly when these modifications occur at substoichiometric levels. The most effective approaches include:

  • Phosphorylation analysis:

    • Phos-tag™ SDS-PAGE followed by Western blotting with YEH1 antibodies

    • Immunoprecipitation with YEH1 antibodies followed by phospho-specific antibody detection

    • Mass spectrometry analysis of enriched phosphopeptides

    • Lambda phosphatase treatment controls to confirm phosphorylation specificity

  • Ubiquitination detection:

    • Denaturing immunoprecipitation to disrupt non-covalent interactions

    • Tandem ubiquitin-binding entity (TUBE) enrichment prior to YEH1 antibody detection

    • Sequential immunoprecipitation approaches (ubiquitin IP followed by YEH1 detection)

    • Use of proteasome inhibitors to stabilize ubiquitinated species

  • Other PTM analysis techniques:

    • SUMOylation: SUMO-trap pulldown combined with YEH1 antibody detection

    • Acetylation: Immunoprecipitation with pan-acetyl antibodies followed by YEH1 detection

    • Glycosylation: Lectin affinity enrichment prior to YEH1 antibody analysis

  • Validation approaches:

    • Site-directed mutagenesis of putative modification sites

    • In vitro modification assays with purified enzymes

    • Correlation with known physiological stimuli that regulate YEH1 activity

    • Temporal analysis following cellular stress or metabolic shifts

When studying YEH1 PTMs, researchers should consider their potential regulatory impact on subcellular localization, protein stability, and enzymatic activity. Integrating multiple detection methods provides the most comprehensive characterization of YEH1's modification landscape .

How can proximity labeling approaches be combined with YEH1 antibodies to map protein-protein interaction networks?

Proximity labeling methods offer powerful approaches for mapping YEH1 protein interaction networks within their native cellular environment. Integration with YEH1 antibodies enhances these techniques through:

  • BioID/TurboID approach implementation:

    • Generate YEH1-biotin ligase fusion constructs (C-terminal fusion recommended)

    • Validate fusion protein localization and function

    • Optimize biotin concentration and labeling time

    • Perform streptavidin pulldown followed by mass spectrometry

  • APEX2 proximity labeling strategy:

    • Create YEH1-APEX2 fusions

    • Establish optimal H₂O₂ treatment conditions

    • Enrich biotinylated proteins using streptavidin

    • Identify proximity partners via proteomics

  • YEH1 antibody-enhanced validation:

    • Confirm identified interactions by co-immunoprecipitation with YEH1 antibodies

    • Perform reciprocal proximity labeling with key interaction partners

    • Use YEH1 antibodies for spatial co-localization studies

    • Implement comparative analysis between different growth conditions

  • Functional network analysis:

    • Categorize interaction partners by cellular function

    • Identify condition-specific interactions

    • Map interactions onto known lipid metabolism pathways

    • Test functional relevance through genetic interaction studies

To distinguish between stable and transient interactions, researchers should compare proximity labeling results with traditional co-immunoprecipitation data using YEH1 antibodies. This complementary approach helps establish a confidence hierarchy for the identified interactions .

What strategies can resolve inconsistent YEH1 antibody performance across different experimental replicates?

Inconsistent performance of YEH1 antibodies across experimental replicates can significantly impact research reliability. To address this challenge:

  • Antibody quality assessment:

    • Test multiple antibody lots to identify lot-to-lot variability

    • Perform titration experiments to determine optimal working concentrations

    • Validate antibody specificity using YEH1-deficient controls

    • Consider monoclonal alternatives if polyclonal antibodies show inconsistency

  • Sample preparation standardization:

    • Implement strict harvest timing protocols (e.g., consistent OD₆₀₀ for yeast cultures)

    • Standardize lysis conditions (buffer composition, incubation time, temperature)

    • Adopt quantitative protein determination methods

    • Use fresh samples whenever possible or validate freezing protocols

  • Technical parameter optimization:

    • Standardize blocking conditions (agent, concentration, incubation time)

    • Optimize antibody incubation parameters (time, temperature, buffer composition)

    • Establish consistent washing protocols

    • Implement controlled image acquisition settings

  • Data analysis improvements:

    • Use internal controls for normalization

    • Implement quantitative analysis with appropriate statistical methods

    • Document all experimental conditions meticulously

    • Establish acceptance criteria for experimental validity

For critical experiments, researchers should consider parallel analysis using orthogonal detection methods or alternative YEH1 antibodies to increase confidence in their findings. Implementing a quality control program that tracks antibody performance over time can help identify degradation or other sources of variability .

How can researchers address epitope masking issues when detecting YEH1 in different subcellular compartments?

YEH1's localization to different subcellular compartments can present challenges for antibody detection due to epitope masking effects. To overcome these obstacles:

  • Sample preparation modifications:

    • Optimize fixation protocols (duration, fixative type, temperature)

    • Test different permeabilization agents (Triton X-100, saponin, digitonin)

    • Evaluate antigen retrieval methods for fixed samples

    • Consider native vs. denaturing conditions based on epitope characteristics

  • Subcellular fraction-specific approaches:

    • For membrane-associated YEH1: Use mild detergents to preserve structure

    • For lipid droplet-associated YEH1: Implement specialized extraction protocols

    • For cytosolic pools: Develop differential extraction methods

    • For potential nuclear localization: Optimize nuclear isolation procedures

  • Epitope accessibility enhancement:

    • Test multiple antibodies targeting different epitopes

    • Consider enzymatic treatments to expose hidden epitopes

    • Evaluate different blocking agents to reduce background while preserving specificity

    • Implement longer incubation times at lower antibody concentrations

  • Complementary validation approaches:

    • Use epitope-tagged YEH1 constructs for parallel detection

    • Perform subcellular fractionation followed by immunoblotting

    • Implement super-resolution microscopy for detailed localization

    • Consider proximity ligation assays for in situ interaction detection

Researchers should document subcellular compartment-specific detection parameters, as optimal conditions may vary significantly between different cellular locations. Cross-validation with fluorescently tagged YEH1 can provide important confirmation of antibody-based localization studies .

What are the key considerations when using YEH1 antibodies for quantitative analysis of protein expression changes?

Using YEH1 antibodies for quantitative analysis requires careful attention to multiple experimental parameters to ensure reliable and reproducible results:

  • Quantitative range determination:

    • Establish the linear detection range for the specific antibody

    • Develop standard curves using recombinant YEH1 or calibrated lysates

    • Determine the lower limit of detection and quantification

    • Verify that experimental samples fall within the established linear range

  • Technical standardization requirements:

    • Maintain consistent protein loading across samples

    • Implement robust loading controls appropriate for the experimental context

    • Use technical replicates to assess method precision

    • Apply identical image acquisition parameters across all samples

  • Data analysis methodology:

    • Select appropriate quantification software with background subtraction capabilities

    • Apply consistent region-of-interest selection criteria

    • Utilize appropriate statistical tests based on experimental design

    • Implement normalization strategies suitable for the specific application

  • Validation of quantitative findings:

    • Confirm changes using orthogonal methods (qPCR, mass spectrometry)

    • Perform spike-in recovery experiments to assess accuracy

    • Evaluate the impact of potential interfering substances

    • Assess reproducibility across independent biological replicates

For time-course experiments or comparative analyses across different growth conditions, researchers should implement rigorous internal controls and consider using multiplexed detection systems to minimize technical variability. When analyzing post-translational modifications, the ratio of modified to total YEH1 provides more reliable information than absolute quantities of modified protein .

How can single-cell analysis techniques be adapted for YEH1 detection to study cell-to-cell variability in yeast populations?

Adapting single-cell analysis for YEH1 detection offers valuable insights into population heterogeneity in lipid metabolism. To implement these approaches effectively:

  • Flow cytometry adaptations:

    • Develop intracellular staining protocols compatible with yeast cell walls

    • Optimize fixation and permeabilization for YEH1 antibody accessibility

    • Implement multi-parameter analysis to correlate YEH1 levels with cellular states

    • Consider fluorescent protein fusions for live-cell analysis

  • Single-cell imaging techniques:

    • Establish high-content imaging workflows with automated cell segmentation

    • Develop quantitative image analysis pipelines for YEH1 intensity measurement

    • Implement microfluidic systems for time-lapse studies of individual cells

    • Combine with organelle-specific markers for colocalization analysis

  • Single-cell 'omics integration:

    • Correlate YEH1 protein levels with transcriptomic data from the same cells

    • Develop compatible protocols for simultaneous protein and lipid analysis

    • Implement index sorting to connect molecular profiles with phenotypic characteristics

    • Consider spatial transcriptomics approaches for tissue or colony organization studies

  • Technical considerations for reliable quantification:

    • Establish consistent autofluorescence correction methods

    • Implement appropriate controls for antibody specificity at the single-cell level

    • Develop computational approaches to distinguish technical from biological variability

    • Consider the impact of cell cycle position on YEH1 expression

What novel antibody engineering approaches could enhance the specificity and sensitivity of YEH1 detection in complex samples?

Enhancing YEH1 antibody performance through advanced engineering approaches can significantly improve detection capabilities:

  • Recombinant antibody fragment development:

    • Generate single-chain variable fragments (scFvs) targeting YEH1-specific epitopes

    • Develop antigen-binding fragments (Fabs) with optimized affinity

    • Engineer bispecific antibodies targeting multiple YEH1 epitopes simultaneously

    • Create intrabodies optimized for intracellular expression and detection

  • Affinity maturation strategies:

    • Implement phage display for selective enrichment of high-affinity variants

    • Apply directed evolution approaches to enhance specificity

    • Utilize computational design to optimize binding interfaces

    • Perform deep mutational scanning to identify optimal antibody sequences

  • Novel conjugation and detection systems:

    • Develop site-specific conjugation methods for consistent labeling

    • Implement proximity-dependent amplification techniques

    • Create split-reporter systems for interaction-dependent detection

    • Engineer antibody-enzyme fusions for localized signal amplification

  • Yeast-specific adaptations:

    • Optimize antibody formats for penetration through yeast cell walls

    • Develop camelid single-domain antibodies (nanobodies) for enhanced accessibility

    • Create antibody derivatives resistant to yeast proteases

    • Engineer pH-resilient variants for detection across cellular compartments

Researchers interested in developing enhanced YEH1 detection reagents should consider collaborating with protein engineering specialists and implement rigorous validation protocols that compare new antibody formats with conventional approaches across a range of experimental conditions .

How might YEH1 antibodies contribute to understanding evolutionary conservation of lipid metabolism pathways across fungal species?

YEH1 antibodies can serve as valuable tools for comparative studies of lipid metabolism across fungal species, providing insights into evolutionary conservation and divergence:

  • Cross-species reactivity assessment:

    • Evaluate YEH1 antibody recognition across related yeast species

    • Perform epitope conservation analysis through sequence alignment

    • Test reactivity in pathogenic fungi with potential YEH1 homologs

    • Create epitope maps to identify invariant regions for broad-specificity antibodies

  • Comparative functional studies:

    • Deploy antibodies to track expression patterns under conserved stress conditions

    • Compare subcellular localization patterns across species

    • Evaluate co-immunoprecipitation patterns to identify conserved interaction networks

    • Assess post-translational modification conservation using specific antibodies

  • Methodological adaptations for diverse fungi:

    • Optimize extraction protocols for different cell wall compositions

    • Adjust immunoprecipitation conditions for species-specific cellular environments

    • Develop standardized quantification approaches for cross-species comparisons

    • Implement native protein analysis techniques for functional assessment

  • Evolutionary implications analysis:

    • Correlate antibody reactivity patterns with phylogenetic relationships

    • Identify species-specific modifications in expression regulation

    • Connect protein expression patterns with adaptive lipid metabolism strategies

    • Document lineage-specific functional divergence

This evolutionary approach can provide valuable insights into the core conserved functions of YEH1 versus species-specific adaptations, potentially revealing new targets for antifungal development or biotechnological applications. Researchers should combine antibody-based studies with genomic and biochemical approaches for comprehensive evolutionary analysis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.